Clonality can be established by a lack of mosaicism in a female due to the random inactivation of either the maternal or paternal X-chromosome early in embryogenesis. The methylation status of CpG sites close to the trinucleotide repeats in exon 1 of the human androgen receptor (AR) Xchromosome gene (HUMARA) has been used for a determination of clonality. This HUMARA assay at times indicated clonal hematopoiesis in healthy elderly females, thus precluding its applicability. We used a clonality assay based on quantitative expression of polymorphic Xchromosome genes (qTCA) and found no evidence of clonal hematopoiesis in healthy nonanemic elderlies. We found instances of discordance between HUMARA results and those obtained by pyrosequencing and qTCA methods, as well as by directly quantifying AR gene expression. To determine the basis of this discrepancy we examined the methylation pattern of the AR locus subject to HUMARA assay. Notably, we found the extent of DNA methylation to be highly variable at the AR gene in granulocytes of individuals with discordant results and also in BFU-E colonies but not in those with clonal hematopoiesis. These data provide the molecular basis of incomplete correlation with the pattern of DNA methylation of this X-chromosome AR gene locus.
INTRODUCTION
Determination of clonality based on assays of inactivation of genes encoded on the Xchromosome has provided important insights into the origins of neoplastic diseases, helped to decipher the hierarchy of hematopoiesis, and provided a mechanism for differentiating between inherited and acquired disorders, for distinguishing between clonal and reactive acquired hematological abnormalities and for demonstrating cell selection in female carriers of X-linked inherited processes 1 . The characteristics that make a clonality assay informative and widely applicable include the following: (1) The gene or genes that are being assayed must undergo Xinactivation such that only one isoform is faithfully expressed in each individual somatic cell; (2) The gene or genes of interest need to be sufficiently polymorphic so as to be useful for analysis in a high proportion of the population; (3) The assay should be quantitative because skewing of X-inactivation is a normal biological process determined by the portion of cells with either an active paternal or maternal X-chromosome, a process that occurs randomly during embryogenesis wherein only few cells contribute to the tissues studied; (4) The gene or genes being interrogated should be widely expressed and the assay should be sufficiently robust so that accurate quantitative determinations can be made using a variety of tissues. The discovery of trinucleotide repeats in exon 1 of the AR gene (>1,000 bp downstream from AR gene promoter and transcription initiation site) and assessing the DNA methylation status of adjacent CpG sites provided a convenient, fast, and widely used HUMARA assay for measuring clonality 2 and appeared to fulfill these criteria, although it does not directly quantify gene or protein expression 3 .
Oligoclonal hematopoiesis based on skewed AR methylation was reported in healthy elderly females and, thus, it was suggested that clonality assays based on X-chromosome
For personal use only. on October 24, 2017. by guest www.bloodjournal.org From inactivation are not applicable for the elderly [4] [5] [6] . However, the methylation status of loci on the inactive X-chromosome is heterogeneous, with some loci on inactive X-chromosome hypomethylated, while others are hypermethylated or had no recognizable methylation differences 7, 8 . As a result, we have developed an alternate method that differentiates active from inactive X-chromosome genes in females, known as transcriptional clonality assays (TCA) [7] [8] [9] [10] .
We recently provided evidence that oligoclonal or clonal hematopoiesis was not present in 40
healthy females (all having normal blood counts; age in years: range, 65-92; median, 82) when assessed by the quantitative TCA (qTCA) assay, while about one-third of these females had skewed methylation patterns of the AR locus 11 . These results have recently been challenged by a report of concordance between methylation of the AR locus and X-chromosome transcriptional allelic usage
12
. However, the healthy individuals with skewed methylation of the AR locus were not separately analyzed for skewing of X-chromosome allelic usage by qTCA, and it also appeared that the qTCA assay was not performed as originally described 13 .
To address these issues, we extended our original experimental design to include studies in young, healthy controls using another well-validated quantitative method, pyrosequencing, to measure expression of polymorphic X-chromosome genes; these experiments were performed in a blinded fashion by an investigator at a separate institution (JJ). The results of the two qTCA methods were compared pair-wise with results using both the HUMARA method and quantitative expression of AR. Herein, we report a concordance between the two qTCA methods, while in cases of extreme skewing of X-inactivation as determined by HUMARA in normal subjects but not in those with clonal hematopoiesis, we observed discordance with the results of qTCA and pyrosequencing. These results further validate the accuracy of our qTCA
For personal use only. on October 24, 2017. by guest www.bloodjournal.org From and indicate that extreme skewing of X-chromosome inactivation is not a common variation of normal hematopoiesis.
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MATERIALS AND METHODS

Study Subjects
This study included the following two groups of prospectively recruited subjects: 1) young, healthy females (n=31; mean age, 35 years; median age, 34 years), and 2) females with JAK2V617F-positive myeloproliferative neoplasms (six with polycythemia vera and one with essential thrombocythemia), as well as 3) three healthy men. After signing an approved University of Utah Institutional Review Board informed consent in accordance with the Declaration of Helsinki, 10 mL of peripheral blood was obtained by venipuncture. Granulocyte, platelet and mononuclear cell fractions were isolated according to previously published protocols 14, 15 .
Genotyping of X-chromosome single nucleotide exonic polymorphisms
Genomic DNA was isolated from granulocytes using the Puregene DNA purification kit (Gentra, MN, USA). Genotyping of single nucleotide exonic polymorphisms from five X-chromosome genes all previously demonstrated to be subject to X-chromosome inactivation [dbSNP1135363 (C/T) in BTK; dbSNP 9018 (G/A) in FHL1; dbSNP 1141608 (C/T) in IDS; dbSNP 2230037 (C/T) in G6PD; dbSNP 1126762 (G/T) in MPP1] was performed using TaqMan allele-discrimination assays 11 analyzed using an Applied Biosystems 7500 Sequence Detection System (Applied Biosystems, CA, USA), as described by the manufacturer. The three X-chromosome genes (FHL1, IDS and MPP1) with the greatest frequency of heterozygosity were selected for comparison of expression by both qTCA and pyrosequencing.
Quantitative transcriptional clonality assay (qTCA)
Total RNA was isolated from granulocytes and platelets using Tri-Reagent (Molecular Research Center, OH, USA) and used for assessment of allelic usage ratio of the three most informative Xchromosome polymorphic genes. Aliquots of 1 µg of total RNA were treated using the DNA-free Kit (Ambion) to remove any contaminating DNA. Aliquots of 200 ng of DNA-free RNA were reverse-transcribed using SuperScript VILO for qRT-PCR (Invitrogen, CA, USA). Quantitative allele-specific PCR (qRT-AS-PCR) was performed 11 employing a Sequence 7500 Detection System (Applied Biosystems, Foster City CA, USA), in which an allele-specific primer, containing both a mismatched nucleotide and a locked nucleic acid, is used to enhance discrimination between the polymorphic nucleotides using reaction conditions previously described 11 . Aliquots of cDNA from informative subjects (those heterozygous at any of the Xchromosome loci) were shipped to MD Anderson Cancer Center, Houston, Texas, for independent qTCA analyses by pyrosequencing in the laboratory of one of the authors (JJ).
DNA-HUMARA
HUMARA was performed as previously described 11, 16 . DNA-HUMARA employs a methylation sensitive nuclease to digest the unmethylated (active) allele. In this assay, allelic ratios were determined by an equation that calculates the amount of PCR product generated by the allele with the longest microsatellite. The relative amount of the shorter of the two alleles (allele A) is assigned a value (in percent) by subtracting the amount of the longer allele (allele B) in percent from 100%. Therefore, unlike the qTCA, the frequency of each allele is not directly quantified in separate PCR reactions in DNA-HUMARA. PCR products generated from granulocyte DNA were quantified using an ABI PRISM 3130 Automatic Genetic Analyzer (Applied Biosystems, CA, USA), and the ratio of active to inactive X-chromosome was determined as described by 
RNA-HUMARA
This RNA-HUMARA is based on AR RNA expression, with polymorphisms determined by the length of the microsatellite cDNA transcripts of exon 1 of AR. In this assay, the PCR cDNA products are subjected to capillary electrophoresis, and the allele expression frequency is determined by quantitating the amount of each of the two different size alleles represented in the PCR product. We quantified AR transcripts using the method described by Busque et al 2 . Total RNA was isolated from granulocytes using Tri-Reagent (Molecular Research Center, OH, USA), and treated with DNA-free Kit reagents (Ambion, Austin, TX USA) to remove any contaminating DNA. Next, 200 ng of DNA-free RNA were reverse-transcribed using SuperScript VILO in preparation for qRT-PCR (Invitrogen, CA, USA). A mock reverse transcription reaction lacking reverse transcriptase was performed to ensure that no residual DNA contaminated the cDNA preparations. Two microliters of AR cDNA were added to 18 uL of PCR mix and, following amplification, the PCR products were analyzed and quantified using an ABI PRISM 3130
Automatic Genetic Analyzer (Applied Biosystems, CA, USA).
Quantification of single nucleotide polymorphisms (SNPs) by pyrosequencing analysis
We developed pyrosequencing assays for quantitative detection of exonic SNPs in the following X-chromosome genes: FHL1, rs9018; IDS, rs1141608; MPP1, rs1126762; AR, rs6153, rs9332969, rs9332970, rs9332971, rs9332972, rs6154. To decrease the expense and labor, pyrosequencing was not developed for BTK and G6PD exonic polymorphisms because of their lower polymorphic rates among US females 1, 17 . Granulocyte genomic DNA and cDNA were prepared in Salt Lake City, and aliquots were shipped to MD Anderson Cancer Center, Houston, TX. Granulocyte cDNA and genomic DNA (40 ng per reaction) were amplified with genespecific primers in two-step semi-nested polymerase chain reactions. The second step PCR was used to label one DNA strand with biotin using a universal primer tag biotinylated at the 5΄end 19 , 20 nmol/L, was used in the first step PCR to achieve a hot start.
The sequences of PCR and pyrosequencing primers are listed in Supplementary Table 1 .
The following PCR conditions were used: initial denaturation at 95°C for 5 minutes, followed by 40 cycles of denaturation at 94°C for 15 seconds and annealing/extension at 60°C for 1 minute.
We measured the percentage of polymorphic single nucleotides by pyrosequencing with the PSQ HS 96 Pyrosequencing System (Qiagen, Charlottesville, VA) and Pyro Gold CDT Reagents (Qiagen), as previously described 20 .
BFU-Es (burst-forming unit-erythroid) analysis.
Erythroid colonies were grown from BFU-E progenitors in peripheral blood mononuclear cells in the presence of erythropoietin (EPO) at 3 U/ml 21, 22 . Individual colonies were picked, genomic DNA and total RNA isolated, their clonality determined by DNA-HUMARA.
Bisulfite modification of DNA
Genomic DNA from granulocytes, BFU-E colonies and an induced pluripotent stem cell (iPSC), line (PVb1.11 p19) 23 , were modified by sodium bisulfite EpiTect Bisulfite kit (Qiagen, Charlottesville, VA) following the manufacturer's protocol.
Semi-nested two-step bisulfite-specific HUMARA exon1 PCR
For the HUMARA exon1 amplification, a semi-nested two-step bisulfite PCR approach was for the semi-nested reaction, and 30 sec at 72°C. In the second semi-nested reaction 2 ul of the first PCR product was used.
Methylation detection at control imprinted genes H19 and SNRPN
Two autosomal genes subjected to imprinting were used as a control for our methylation analyses. For the H19 in promoter region amplification, a semi-nested bisulfite PCR approach was used. In the second semi-nested reaction, 2 ul of the first PCR product was used. The SNRPN exon 1 amplification was performed as described by Zeschnigk et al 24 .
Bisulfite sequencing and DNA methylation analysis.
After purification of PCR products with the QIAquick gel extraction kit (Qiagen, Charlottesville, VA), individual PCR products were inserted into pCR®2. These data confirm that both qTCA and DNA-HUMARA unambiguously detect clonality in myeloproliferative neoplasms 25 . However, when HUMARA-RNA was analyzed in these clonal subjects, the results for patient P4, (Table 1) , were not consistent with clonality (assuming clonality is allele ratio of ≥ 75:25).
Comparison of qTCA and Pyrosequencing Analyses with HUMARA Results
Genotyping of exonic SNPs in X-chromosome genes MPP1, FL1 and IDS and the AR locus exon 1
microsatellite marker. Twenty-five of 31 (81%) of the healthy volunteer women were found to be heterozygous in one or more of the three polymorphic X-chromosome genes included in this study, while 29 of 31 (94%) were heterozygous based on allelic differences in the number of CAG repeats in the AR locus (Table 2 ). This rate of heterozygosity using these two approaches (informativeness for the clonality analyses) is not significantly different at p=0.1297.
Comparison of allelic expression ratios of X-chromosome exonic SNPs by qTCA and
pyrosequencing. Both qTCA and quantitative pyrosequencing were performed using cDNA generated from RNA extracted from peripheral blood granulocytes, assaying exonic SNPs in (Table 2) . For each individual gene, the same SNP was quantified by both qTCA and pyrosequencing (Table 2 ). In the case of the qTCAs, each polymorphic allele was quantified in a separate PCR reaction, with any difference in amplification efficiency between allele specific PCR reactions being taken into account in the equation used to calculate the frequency of expression of each of the two polymorphic alleles for each gene 22, 26 . While the results shown in Table 2 are the mean of duplicate determination, we validated the accuracy and reproducibility of the assay by randomly selecting samples for analysis in separate PCR reactions (data not shown).
MPP1, IDS and FHL1
Additionally, we compared qTCA results generated using platelet cDNA with results using granulocyte cDNA, and qTCA data in those women heterozygous for more than one gene using multiple informative gene analyses; in both evaluations (data not shown), we found a high degree of correlation as previously reported [9] [10] [11] . In pyrosequencing analyses, quantification of expression of polymorphic alleles is based on the heights of the peaks generated on the pyrograms by each allele ( Supplementary Fig. 1 ).
When the results of qTCA were compared with those of pyrosequencing, a good correlation was observed for each of the three genes analyzed (Fig. 1) .
Comparison of qTCA with DNA-HUMARA and RNA-HUMARA in the cohort of young,
healthy women
Comparison of qTCA with DNA-HUMARA (see Figure 2A ). Twenty-nine subjects (age range in years: 22-55; mean: 35; median: 34) were found to be heterozygous based on the number of CAG repeats in exon 1 of AR (Table 2 ). Based on DNA-HUMARA, 9 of 29 of healthy young females (31%) had extreme skewing of granulocyte AR methylation pattern (to allow direct comparison with published HUMARA data defined as an allele ratio of finding similar to that observed in our previous study in which 9 of 26 (35%) elderly healthy volunteers were found to have an extremely skewed ratio of exon 1 differentially methylated microsatellite polymorphic repeats AR gene 11 . Of the 9 subjects with extreme skewing of the AR methylation pattern, three were homozygous (noninformative) for any of the three genes used in the qTCA/quantitative pyrosequencing assay (Table 2 , dark shaded rows) and six were informative ( Table 2 , light shaded rows). One subject (YC17) also had extreme skewing of Xinactivation in both the qTCA and the quantitative pyrosequencing assay; she is healthy, with normal blood counts and no historical evidence of being a carrier for any X-chromosome-linked disorders subject to selection 1 . The results of these experiments demonstrate that, unlike the case for the DNA-HUMARA, extreme skewing of X-inactivation is far less frequent in normal young females when qTCA or quantitative pyrosequencing are employed, yet it was in our small study still detected in 1 out of 29 samples. In this individual the mechanism of extreme skewing may be random, selection for any of X-chromosome alleles exerting the different proliferative/survival impact 1 at hematopoietic progeny, or any other known or not yet delineated factor(s) impacting X-chromosome inactivation.
Comparison of qTCA with . To analyze the transcripts of the AR gene, we developed a quantitative pyrosequencing assay for six AR exonic SNPs separate from the microsatellite repeats measured by HUMARA, (rs6153, rs9332969, rs9332970, rs9332971, rs9332972, rs6154), but these SNPs were found to be insufficiently polymorphic among subjects in the study cohort to be informative. Therefore, to compare the results generated by DNA-HUMARA with those derived from an expression-based assay utilizing microsatellite RNA repeats measured by HUMARA, the method of Busque et al AR gene was observed in five subjects (YC17, YC19, YC3, YC5 and YC29), with extreme skewing determined by DNA-HUMARA but not by RNA-HUMARA ( A separate analysis of the data in Table 2 also revealed discordance between results generated by qTCA/pyrosequencing and both DNA-HUMARA and RNA-HUMARA. To analyze these relationships, for each informative subject, the mean of the proportion of the dominant allele of the informative polymorphic genes, as determined by qTCA, were compared with those obtained by DNA-HUMARA ( Fig. 2A ) and RNA-HUMARA (Fig. 2B) . In both cases, the linear relationship was found to be statistically insignificant (p≥0.05), although the relationship between qTCA and DNA-HUMARA approached statistical significance (p=0.0504, Fig 2A) . Moreover, direct comparison of DNA-HUMARA results with those generated by RNA-HUMARA was also shown to be statistically insignificant (Fig. 2C) . These results support the hypothesis that the pattern of DNA methylation does not faithfully reflect X-inactivation or determine AR allele expression. However, that RNA-HUMARA does not correlate with qTCA results also suggests that silencing of AR expression on the inactive X-chromosome may be incomplete in normal females.
Analysis of clonality in the individual BFU-colonies of young healthy women
Individual BFU-E colonies from subject YC17 were analyzed for the clonality by DNA-HUMARA and qPCR. One-hundred sixty BFU-E colonies were analyzed by DNA-HUMARA; Sufficient amount of RNA for qTCA analyses from 97 colonies each indicating a single allelic
For personal use only. on October 24, 2017. by guest www.bloodjournal.org From transcript were obtained; this included 40 colonies assayed for MPP1 (34 colonies expressed G allele and 6 T allele) and 10, 16, 14 and 17 colonies assayed for G6PD, IDS, FHL1 and BTK expression, respectively, for G6PD (8 colonies expressed C allele and 2 T allele), IDS (13 colonies expressed C allele and 3 expressed T allele), FHL1 (12 colonies expressed C allele and 2 expressed T allele), BTK (14 colonies expressed C allele and 3 expressed T allele). In contrast, only from 35 individual colonies we were able to amplify exon 1 of the AR gene for both digested and undigested DNA HUMARA analyses (data not shown).
Patterns of CpG methylation of the human androgen receptor gene HUMARA by bisulfite sequencing in native selected granulocytes and colonies from individual BFU-E
To determine the molecular basis of the discrepancy between qTCA analyses and HUMARA, we assessed the methylation status of CpG loci of the AR DNA segment that was subject to HUMARA using standard bisulfite treatment. Granulocyte DNA from healthy controls whose analyses of X-chromosome inactivation by DNA and RNA HUMARA assays and qTCA were discordant (YC3, YC17, YC18 and YC25), were examined, and demonstrated in each instance a heterogeneous pattern of methylation at AR locus, as shown in Figure 3A . In contrast, patients with myeloproliferative neoplasms (PV-3, PV-5 and PV-7) demonstrated more homogenous methylation patterns of the AR locus, as shown in Supplementary Figure 2A . As a control, we examined the methylation pattern of granulocyte DNA from healthy male controls (bearing a single active X-chromosome) which revealed a fully unmethylated AR locus, indicating a lack of bias of the bisulfite analysis procedure (Supplementary Figure 2B) . The predominance of shorter allele A is evident from our results, which is most likely caused by preferential amplification of this allele, as seen also with DNA-HUMARA. While DNA-HUMARA has implemented correction in the final calculation of allele ratios, this has not been applied for correction of CpG methylation pattern shown here. Furthermore, the heterogeneous pattern of methylation in this polymorphic exon 1 AR locus was also detected in clonal single cell progenies in all individual in vitro expanded single erythroid progenitors, as analyzed by BFU-E colonies (Fig. 3B ) from subject YC17 again, both methylated and unmethylated AR DNA were clearly detected in the same BFU-E colony.
Methylation detection at control genes H19 (Imprinted Maternally Expressed Transcript (non-protein coding)) and SNRPN (Small Nuclear Ribonucleoprotein Polypeptide N)
To further determine the reliability of the bisulfite method, we examined the methylation status of CpGs in two autosomal imprinted genes H19 and SNRPN 24, 27 . Both genes were expressed in iPSC line, but only SNRPN was expressed in granulocytes (data not shown). Aligned with expectations, the H19 gene in iPSC line showed a uniformly and completely methylated pattern on one allele and a lack of methylation on the other allele, in contrast to the results obtained from granulocytes, where this gene is not expressed and where only methylated allele was found (Supplementary Figure 2C) . In addition, the SNRPN gene from granulocytes was completely unmethylated on one allele and methylated on the other (Supplementary Figure 2C , lower right).
Taken together, our controls verify the accuracy of our bisulfite determinations and support our ability to determine the concordance of DNA methylation with gene expression.
DISCUSSION
Detection of clonality based on X-chromosome inactivation requires discrimination of the active from the inactive X-chromosome. Discovery of a polymorphic tri-nucleotide tandem repeat in exon 1 of AR gene that is subject to differential methylation was exploited to develop the convenient HUMARA clonality assay, with its usefulness confirmed in multiple applications.
HUMARA results were generally shown to correlate with X-chromosome inactivation, and the method expanded the feasibility of clonality studies because of the high frequency with which microsatellite polymorphisms are observed in the AR locus and the relative ease of obtaining DNA from tissues of interest and their analysis 1,3 . However, in some cases, the clonality data obtained by methylation-based HUMARA assays were difficult to interpret 28, 29 . Alternative methods were developed to investigate clonality based on quantitative analysis of the expression of genes subject to X-inactivation 7,9 . Previously, we reported a quantitative TCA based on thermostable ligase detection [7] [8] [9] . This method, however, was cumbersome technically and required a large amount of radioisotope, making it impractical for large-scale clinical studies.
More recently, we described the qTCA method to measure allele-specific expression of five Xchromosome genes based on quantification of exonic SNPs 11, 28, 30 . Although based on allelespecific PCR, qTCA is more robust than the standard method because it uses primers that include both a mismatched nucleotide and an artificial locked nucleic acid in the design 22 . These modifications enhance the stability of extension products, thereby improving both the specificity and discrimination power of the assay and has greater sensitivity than a widely used pyrosequencing method wherein the analyzed products less than 5% of total are difficult to detect 22 .
Using this qTCA, we revisited the reported phenomenon of extreme skewing of Xinactivation ratios in myeloid blood cells of aging women 11 . We studied 40 healthy, elderly females using our qTCA and did not find X-chromosome monoallelic expression or extreme
skewing. Yet when we analyzed the same subjects using DNA-HUMARA, we found, in agreement with the studies of others 4-6 , a monoallelic AR methylation pattern in approximately one-third of the subjects. These data were recently challenged by Busque and colleagues 12 , who reported concordance between DNA-HUMARA and two expression-based clonality assays, including one patterned after our qTCA. However, we noted differences in their study design compared to ours. Specifically, the healthy individuals with skewed methylation of the AR locus were not separately analyzed for skewing of X-chromosome allelic usage by one or both qTCA methods; their qTCA method differed in their primer design, only one polymorphic gene (IDS)
was analyzed, and a single cell expanded hematopoietic colonies were not studied. In our studies, we used five X-chromosome conservative SNP polymorphisms of genes shown to be subject to complete X-chromosome inactivation and two separate blood cell types, both granulocytes and platelets, were analyzed, with concordant results 11 . In order to resolve this controversy, we recruited subjects with clonal hematopoiesis and the results of DNA-HUMARA and qTCA were concordant.
We then analyzed 31 healthy female volunteers (age in years, range: 22-55; mean: 35; median: 34). First, when the aliquots of blinded samples were assayed by qTCA method, as well as by a well-established quantitative pyrosequencing method for the detection of single nucleotide polymorphism based on the detection of pyrophosphate release during nucleotide incorporation, which was performed in another institution by an independent investigator (JJ). In this report, we confirm the reproducibility and accuracy of qTCA assay in the evaluation of the X-chromosome allelic expression (Fig. 1) . However, in some instances, a lack of concordance between these two separate qTCA and DNA-HUMARA results ( Fig. 2A) was again noted.
Analogous to previously obtained results for the healthy elderly females, we found some younger healthy females with extreme skewing and apparent monoallelic methylation patterns of the AR locus ( Table 2 ) that were discordant with results of allele expression ratios obtained by qTCA (Fig. 2B) . Moreover, we also observed a lack of concordance of the AR gene allelic expression ratios when the locus DNA methylation was compared to its expression in some studied healthy females (YC17, YC3, YC29 see Table 1 and Fig. 2C ). The basis of this disparity is speculative, but a plausible explanation is that methylation of the CpG sites in exon 1 of the AR gene is distant from its promoter and may not always correlate with gene silencing. Furthermore its transcription-start site (also more than 1 kb downstream from of polymorphic microsatelite exon 1 region) is not located in a CpG island 29, 31 . DNA methylation is an important component of epigenetic regulation of gene expression; however, total methylation content does not always correlate with gene expression as the methyl content of the active X-chromosome has been reported to be twice as high as that for its inactive counterpart 32 . Rather, X-specific methylation of CpG islands determines the extent of gene expression from the gene linked to the island, and as noted above, HUMARA does not assess methylation of AR CpG promoter islands. Thus, we suggest that discordance occurs when the methylation status of the exon 1 region does not extend to the CpG island and promoter region. Thus, the promoter and exon 1 region may be a location where DNA methylation dynamics take place in the cells of normal healthy females, where full or partial demethylation may contract and expand resulting in a heterogeneous pattern; a dynamic that may be compromised or lost in clones derived from myeloproliferative disorders (see below). Discordance between results of qTCA as compared with those of RNA-HUMARA (Fig.   2B ) implies incomplete or inconsistent silencing of AR expression. This interpretation is based on studies using a mouse/human somatic cell hybrid system demonstrating that the genes analyzed in the qTCA are completely and consistently silenced on the inactive X-chromosome 33 .
While the basis of the proposed incomplete/inconsistent silencing of the AR gene is uncertain, leaky expression from the inactive X-chromosome has been reported for a number of genes 13 .
Incomplete silencing may result from failure of the initial spreading of inactivation along the chromosome, lack of an X-inactivation maintenance step in progeny, or both. Paradoxically, methylation of some loci have been reported to be associated with gene activation
32
, and genomic DNA sequence has been implicated in the control of human X-chromosome inactivation [34] [35] [36] , with the presence of short repetitive motifs contributing to the escape process.
However, based on results achieved from individual BFU-E colonies, we confirmed that all 5 Xchromosome genes MPP1, FL1, IDS, G6PD and BTK had their inactive X-chromosome allele completely silenced at progenies of a single cell expanded in vitro for 14 days in BFU-E assays.
In contrast to the observations in the control cohort, concordance between the results of qTCA and DNA-HUMARA were observed for patients with JAK2V617F+ myeloproliferative neoplasms (Table 1) . Thus the processes that confound interpretation of DNA-HUMARA when applied to myeloid cells from normal subjects appear absent in clonalmyeloid myeloproliferative neoplasms.
To determine the basis of the discrepancy in the HUMARA and qTCA results observed in certain healthy subjects, we examined the methylation pattern of the AR locus used for the HUMARA assay in patient granulocytes using bisulfite sequencing. Individuals with discordant HUMARA and qTCA had a heterogeneous pattern of methylation at the polymorphic exon 1 AR locus (Fig. 3A) . Further, we also found the heterogeneous methylation patterns at this AR locus in the individual in vitro expanded single erythroid progenitors to BFU-E colonies (Fig. 3B) . In contrast, patients with myeloproliferative neoplasms who represent clonal hematopoiesis demonstrate more homogenous methylation patterns of the AR locus, as shown in Supplementary   Figure 2A . Presently, the basis of this difference of methylation patterns between normal and clonal tissues remains obscure. However, the technical veracity of our data was confirmed when the same bisulfite sequencing was applied to single X-chromosome male DNA and monoallelicaly expressed imprinted H19 and SNRPN autosomal genes.
Definition of clonality based on qTCA
The exact timing of molecular mechanism of X-chromosome inactivation is not exactly known.
It is generally agreed that this first recognized epigenetic process is mediated by XIST (Xinactive specific transcript) RNA. Some work suggests that the XIST RNA accumulates on one of the two X chromosomes in blastocyst around the 8-cell stage and transcriptionally silences this X-chromosome. 37 Other work suggests that there is a considerable diversity in the timing of this process in placental mammals and in humans the XIST RNA accumulates only in the postblastocyst stage.
38
However our previous studies 10, 11 , and those of others, 39 using the distribution of ranges of Xchromosome transcripts usage ratios in normal healthy females 10, 11 , and work with normal human T cells/mouse cell hybrids 39 have shown that X-inactivation is a stochastic process that occurs at about the eight-cell stage of embryogenesis. Based on these observations, we developed a model to predict the probability of skewing of X-inactivation in normal subjects (Fig. 4) . According to this model, the probability of a normal subject having an allele expression ratio of 100:0 is ~0.4%, the probability of having a ratio of 87.5:12.5 is ~3% and the probability For personal use only. on October 24, 2017. by guest www.bloodjournal.org From of having a ratio of 75:25 is ~11%. Based on this information, we use a ratio of ≥ 80:20 to define clonality, accepting that ~5% of normal females will have skewing of X-inactivation sufficient to be classified as clonal hematopoiesis. This assumption is consistent with observations from the cohort described herein, as one (YC17) of 25 (4%) of the informative subjects had an allele ratio of ≥ 80:20 (Table 2 ). The number of false-positive controls could be reduced by increasing the ratio, but doing so would likely eliminate some true-positive samples, as shown by the results in Table 1 (patients P4 and P6). In this situation, clonal myeloid cells may be contaminated by nonclonal T-lymphocytes, or the granulocytes may be composed of variable proportions of monoclonal and polyclonal cells. A corollary argument is that a clone may expand insufficiently to shift the allele ratio into the clonal category, resulting in a falsenegative interpretation. Our clonality assay system has additional controls designed to reduce false-positive and false-negative results, as concordance among all informative polymorphic genes must be observed (as many as five genes may be polymorphic in a test subject 11 ) and both granulocyte and platelet cDNA is assayed 11 . Moreover, as noted in the Results section (Comparison of qTCA with DNA-HUMARA and RNA-HUMARA in the cohort of young healthy women), qTCA directly quantifies both polymorphic alleles, in contrast to HUMARA in which one allele is quantified directly and the quantity of the other allele is derived.
The observations reported herein further validate the use of qTCA for analysis of clonal hematopoiesis, and provide the molecular basis of the incomplete correlation of HUMARA and qTCA results seen in some individuals as due to the heterogeneous pattern of DNA methylation at this particular AR gene locus. 
For personal use only. on October 24, 2017. by guest www.bloodjournal.org From IDS (lower left panel) . Data points were generated based on data in Table 2 . For each gene, a statistically significant correlation (p≤<0.0001) was observed when expression based on qTCA was compared with that based on quantitative pyrosequencing. 
